Mexico Lists Clinical Trial of CAR-T Cells to Treat Leukemia in Adults After Cofepris Endorsement
10 Articles
10 Articles
Mexico will conduct its first clinical trial with CAR-T cells produced in the country for adult patients with recurrent or refractory acute lymphoblastic leukemia.
CAR-T therapy genetically modifies T lymphocytes to identify and fight cancerous tumors
Cofepris authorized UANL's first fully manufactured CAR-T cell clinical trial in Mexico against leukemia. The post Cofepris approves the first clinical trial with CAR-T cells produced in Mexico appeared first on Almomento News, national and international information.
The nationally manufactured CAR-T cell trial will be conducted at the University Hospital of Nuevo León. The UANL charge will apply unpublished clinical trial against leukemia first appeared in Eleven News.
The Federal Commission for the Protection against Health Risks (Cofepris) authorized the first clinical trial in Mexico with completely national-made CAR-T cells, to be carried out by the Autonomous University of Nuevo León (UANL) through the University Hospital “Dr. José Eleuterio González”. The study, identified with protocol number 7192, is aimed at adults [...] The Cofepris charge authorizes the first clinical trial with CAR-T cells made in …
Mexico Opens the Door to Its First National CAR-T Therapy Against Leukemia - The Impartial of Oaxaca
Cofepris authorized the first national CAR-T cell trial for adults with acute lymphoblastic leukemia
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
